CT regimen
|
WikiDoc Resources for CT regimen |
|
Articles |
|---|
|
Most recent articles on CT regimen |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on CT regimen at Clinical Trials.gov Clinical Trials on CT regimen at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on CT regimen
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on CT regimen Discussion groups on CT regimen Patient Handouts on CT regimen Directions to Hospitals Treating CT regimen Risk calculators and risk factors for CT regimen
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for CT regimen |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords:
Overview
CT regimen refers to a regimen consisting of Cisplatin, paclitaxel (Taxol) used to treat advanced epithelial ovarian cancer.[1]
Regimen
CCisplatin
TPaclitaxel (Taxol)
Indications
References
- ↑ 1.0 1.1 Armstrong DK, Bundy B, Wenzel L, Huang HQ, Baergen R, Lele S; et al. (2006). "Intraperitoneal cisplatin and paclitaxel in ovarian cancer". N Engl J Med. 354 (1): 34–43. doi:10.1056/NEJMoa052985. PMID 16394300.